West Nile virus Matrix Peptide

GeneTex

West Nile virus Matrix Peptide

9

Neutralisation/Blocking

Research Use Only

0.20 mg/ml

Unconjugated

POLY

polyprotein;truncated polyprotein NS1 prime

WNVgp1, polyprotein;truncated polyprotein NS1 prime, RNA-dependent RNA polymerase NS5, anchored capsid protein ancC, capsid protein C, envelope protein E, membrane glycoprotein M, membrane glycoprotein precursor prM, nonstructural protein NS1, nonstructural protein NS1 prime, nonstructural protein NS2A, nonstructural protein NS2B, nonstructural protein NS3, nonstructural protein NS4A, nonstructural protein NS4B, protein 2K, protein pr

West Nile virus peptide is used for blocking the activity of West Nile Virus Matrix Protein antibody (Cat. No. GTX85511). It usually blocks the West Nile Virus antibody activity completely in ELISA by incubating the peptide with equal volume of antibody for 30 min at 37oC.

-20°C

41116100

Virus